Bold Insight and The Office of Experience partner to deliver outstanding user experiences.
Back to team page
Hailey Fehrenbach
Senior UX Researcher
Hailey is a classically trained human factors engineer with over 5 years of experience in medical device and healthcare analytics product development. With a background in design, engineering, and research, she delivers useful, usable, and engaging experiences for all customer touch points across medical device and healthcare industries. Her experience spans research on robotic surgical equipment and combination devices for at-home use, to the design and development of neurotech and cardiac diagnostic platforms. Hailey has a BS in Design from the University of Cincinnati and a MS in Industrial and Human Factors Engineering from Wright State University.
Bold facts
Learn more about
Something unique about you summed up in one sentence:
Share an interesting fact:
In your spare time (or if you had spare time), you would absolutely do this:
Your favorite city in the world is...and why?
Your ultimate celebrity dinner party guest list would include...
Long-term personal goal:
Favorite book:
What is your favorite way to give back to the community?
Read our team’s latest bold insights
When designing an experience, are you really thinking about the customer first?
While every organization has constraints to consider when designing experiences for customers or users, designing the ideal customer experience is completely possible within those constraints. Begin by identifying the experience you want your customer to have and work “backward” from there.
UX project logistics: choosing the right vendors for project success
Selecting the correct vendors to support your UX project is critical to success. From facilities to recruiting, knowing the right questions to ask, budget constraints, and client needs and expectations will make the selection process smooth and painless.
Reclassifying diabetes: 3 implications for product design
Recent research suggests that reclassifying diabetes may allow for the development of more targeted diabetes treatments. This could present opportunities to design these treatments to maximize patient safety and experience.